{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T10:08:47Z","timestamp":1769076527007,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There is no established medical therapy to treat biliary fibrosis resulting from chronic inflammation in the biliary tree. We have recently shown that liver-specific over-expression of angiotensin converting enzyme 2 (ACE2) of the renin angiotensin system (RAS) ameliorated liver fibrosis in mice. Diminazene aceturate (DIZE), a small molecule drug approved by the US Food and Drug Administration, which is used to treat human trypanosomiasis, has been shown to have antifibrotic properties by enhancing ACE2 activity. In this study we sought to determine the therapeutic potential of DIZE in biliary fibrosis using bile duct ligated and multiple drug resistant gene-2 knockout mice. Additionally, human hepatic stellate (LX-2) and mouse Kupffer (KUP5) cell lines were used to delineate intracellular pathways. DIZE treatment, both <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>, markedly inhibited the activation of fibroblastic stellate cells which was associated with a reduced activation of Kupffer cells. Moreover, DIZE-inhibited NOX enzyme assembly and ROS generation, activation of profibrotic transcription factors including p38, Erk1\/2 and Smad2\/3 proteins and proinflammatory and profibrotic cytokine release. These changes led to a major reduction in biliary fibrosis in both models without affecting liver ACE2 activity. We conclude that DIZE has a potential to treat biliary fibrosis.<\/jats:p>","DOI":"10.1038\/s41598-018-28490-y","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T10:42:48Z","timestamp":1530268968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4403-7177","authenticated-orcid":false,"given":"Indu G.","family":"Rajapaksha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai Y.","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1863-7539","authenticated-orcid":false,"given":"Louise M.","family":"Burrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Angus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandana B.","family":"Herath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"key":"28490_CR1","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","volume":"90","author":"KN Lazaridis","year":"2015","unstructured":"Lazaridis, K. N. & Larusso, N. F. The cholangiopathies. Mayo Clinic Proceedings 90, 791\u2013800, https:\/\/doi.org\/10.1016\/j.mayocp.2015.03.017 (2015).","journal-title":"Mayo Clinic Proceedings"},{"key":"28490_CR2","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1053\/j.gastro.2010.09.004","volume":"139","author":"GM Hirschfield","year":"2010","unstructured":"Hirschfield, G. M., Heathcote, E. J. & Gershwin, M. E. Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches. Gastroenterology 139, 1481\u20131496, https:\/\/doi.org\/10.1053\/j.gastro.2010.09.004 (2010).","journal-title":"Gastroenterology"},{"key":"28490_CR3","first-page":"60","volume":"96","author":"T P\u00e9rez Fern\u00e1ndez","year":"2004","unstructured":"P\u00e9rez Fern\u00e1ndez, T. et al. Diagnostic and therapeutic approach to cholestatic liver disease. Revista Espanola de Enfermedades Digestivas 96, 60\u201373 (2004).","journal-title":"Revista Espanola de Enfermedades Digestivas"},{"key":"28490_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0001-706X(93)90092-P","volume":"54","author":"AS Peregrine","year":"1993","unstructured":"Peregrine, A. S. & Mamman, M. Pharmacology of diminazene: a review. Acta Tropica 54, 185\u2013203, https:\/\/doi.org\/10.1016\/0001-706X(93)90092-P (1993).","journal-title":"Acta Tropica"},{"key":"28490_CR5","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1164\/rccm.201205-0880OC","volume":"187","author":"V Shenoy","year":"2013","unstructured":"Shenoy, V. et al. Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models. American Journal of Respiratory and Critical Care Medicine 187, 648\u2013657, https:\/\/doi.org\/10.1164\/rccm.201205-0880OC (2013).","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"28490_CR6","first-page":"148","volume":"35","author":"DE Abaru","year":"1984","unstructured":"Abaru, D. E., Liwo, D. A., Isakina, D. & Okori, E. E. Retrospective long-term study of effects of berenil by follow-up of patients treated since 1965. Tropenmedizin und Parasitologie 35, 148\u2013150 (1984).","journal-title":"Tropenmedizin und Parasitologie"},{"key":"28490_CR7","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1177\/1087057111413919","volume":"16","author":"LV Kulemina","year":"2011","unstructured":"Kulemina, L. V. & Ostrov, D. A. Prediction of Off-Target Effects on Angiotensin-Converting Enzyme 2. Journal of Biomolecular Screening 16, 878\u2013885, https:\/\/doi.org\/10.1177\/1087057111413919 (2011).","journal-title":"Journal of Biomolecular Screening"},{"key":"28490_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/0929866522666151013130550","volume":"23","author":"LADM Marilda","year":"2016","unstructured":"Marilda, L. A. D. M. et al. Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats. Protein & Peptide Letters 23, 9\u201316, https:\/\/doi.org\/10.2174\/0929866522666151013130550 (2016).","journal-title":"Protein & Peptide Letters"},{"key":"28490_CR9","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1161\/HYPERTENSIONAHA.113.01337","volume":"62","author":"Y Qi","year":"2013","unstructured":"Qi, Y. et al. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology. Hypertension 62, 746\u2013752, https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01337 (2013).","journal-title":"Hypertension"},{"key":"28490_CR10","doi-asserted-by":"publisher","first-page":"e0118758","DOI":"10.1371\/journal.pone.0118758","volume":"10","author":"E Velkoska","year":"2015","unstructured":"Velkoska, E. et al. Short-Term Treatment with Diminazene Aceturate Ameliorates the Reduction in Kidney ACE2 Activity in Rats with Subtotal Nephrectomy. Plos One 10, e0118758, https:\/\/doi.org\/10.1371\/journal.pone.0118758 (2015).","journal-title":"Plos One"},{"key":"28490_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/HYPERTENSIONAHA.115.05185","volume":"66","author":"DM Bennion","year":"2015","unstructured":"Bennion, D. M. et al. Activation of the Neuroprotective Angiotensin-Converting Enzyme 2 in Rat Ischemic Stroke. Hypertension 66, 141\u2013148, https:\/\/doi.org\/10.1161\/hypertensionaha.115.05185 (2015).","journal-title":"Hypertension"},{"key":"28490_CR12","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/HYPERTENSIONAHA.113.02856","volume":"63","author":"PK Haber","year":"2014","unstructured":"Haber, P. K. et al. ACE2-Independent Action Of Presumed ACE2 Activators: Studies In Vivo, Ex Vivo and In Vitro. Hypertension 63, 774\u2013782, https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.02856 (2014).","journal-title":"Hypertension"},{"key":"28490_CR13","first-page":"305","volume":"65","author":"J Kountouras","year":"1984","unstructured":"Kountouras, J., Billing, B. H. & Scheuer, P. J. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. British journal of experimental pathology 65, 305\u2013311 (1984).","journal-title":"British journal of experimental pathology"},{"key":"28490_CR14","doi-asserted-by":"publisher","unstructured":"Tag, C. G. et al. Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis. Journal of Visualized Experiments: JoVE, 52438, https:\/\/doi.org\/10.3791\/52438 (2015).","DOI":"10.3791\/52438"},{"key":"28490_CR15","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1172\/JCI18212","volume":"112","author":"R Bataller","year":"2003","unstructured":"Bataller, R. et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. Journal of Clinical Investigation 112, 1383\u20131394, https:\/\/doi.org\/10.1172\/JCI200318212 (2003).","journal-title":"Journal of Clinical Investigation"},{"key":"28490_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1080\/17474124.2016.1207523","volume":"10","author":"E Ahmadian","year":"2016","unstructured":"Ahmadian, E., Pennefather, P. S., Eftekhari, A., Heidari, R. & Eghbal, M. A. Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention. Expert Review of Gastroenterology and Hepatology 10, 1279\u20131288, https:\/\/doi.org\/10.1080\/17474124.2016.1207523 (2016).","journal-title":"Expert Review of Gastroenterology and Hepatology"},{"key":"28490_CR17","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/hep.24281","volume":"53","author":"Y-H Paik","year":"2011","unstructured":"Paik, Y.-H. et al. The Nicotinamide Adenine Dinucleotide Phosphate Oxidase Homologues NOX1 and NOX2\/gp91(phox) Mediate Hepatic Fibrosis in Mice. Hepatology (Baltimore, Md.) 53, 1730\u20131741, https:\/\/doi.org\/10.1002\/hep.24281 (2011).","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"28490_CR18","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1111\/j.1440-1746.2007.05277.x","volume":"23","author":"S De Minicis","year":"2008","unstructured":"De Minicis, S. & Brenner, D. A. Oxidative stress in alcoholic liver disease: Role of NADPH oxidase complex. Journal of Gastroenterology and Hepatology 23, S98\u2013S103, https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05277.x (2008).","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"28490_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/bies.950180708","volume":"18","author":"JM Kyriakis","year":"1996","unstructured":"Kyriakis, J. M. & Avruch, J. Protein kinase cascades activated by stress and inflammatory cytokines. BioEssays 18, 567\u2013577, https:\/\/doi.org\/10.1002\/bies.950180708 (1996).","journal-title":"BioEssays"},{"key":"28490_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0014-5793(01)02656-4","volume":"502","author":"S Dooley","year":"2001","unstructured":"Dooley, S. et al. Transforming growth factor \u03b2 signal transduction in hepatic stellate cells via Smad2\/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. FEBS Letters 502, 4\u201310, https:\/\/doi.org\/10.1016\/S0014-5793(01)02656-4 (2001).","journal-title":"FEBS Letters"},{"key":"28490_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1042\/CS20080647","volume":"117","author":"JS Lubel","year":"2009","unstructured":"Lubel, J. S. et al. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat. Clin Sci (Lond) 117, 375\u2013386, https:\/\/doi.org\/10.1042\/CS20080647 (2009).","journal-title":"Clin Sci (Lond)"},{"key":"28490_CR22","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/mt.2015.92","volume":"23","author":"KY Mak","year":"2015","unstructured":"Mak, K. Y. et al. ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice. Mol Ther 23, 1434\u20131443, https:\/\/doi.org\/10.1038\/mt.2015.92 (2015).","journal-title":"Mol Ther"},{"key":"28490_CR23","doi-asserted-by":"crossref","unstructured":"Liu, C. et al. Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats. Lab Invest 90, 1805\u20131816, http:\/\/www.nature.com\/labinvest\/journal\/v90\/n12\/suppinfo\/labinvest2010123s1.html (2010).","DOI":"10.1038\/labinvest.2010.123"},{"key":"28490_CR24","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/hep.1840190529","volume":"19","author":"MJ Czaja","year":"1994","unstructured":"Czaja, M. J., Xu, J., Ju, Y., Alt, E. & Schmiedeberg, P. Lipopolysaccharide-neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration. Hepatology 19, 1282\u20131289, https:\/\/doi.org\/10.1002\/hep.1840190529 (1994).","journal-title":"Hepatology"},{"key":"28490_CR25","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0168-8278(95)80009-3","volume":"23","author":"AMBC Tiggelman","year":"1995","unstructured":"Tiggelman, A. M. B. C. et al. Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-l\u03b2 and TNF\u03b1. Journal of Hepatology 23, 295\u2013306, https:\/\/doi.org\/10.1016\/S0168-8278(95)80009-3 (1995).","journal-title":"Journal of Hepatology"},{"key":"28490_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","volume":"347","author":"S Dooley","year":"2012","unstructured":"Dooley, S. & ten Dijke, P. TGF-\u03b2 in progression of liver disease. Cell and Tissue Research 347, 245\u2013256, https:\/\/doi.org\/10.1007\/s00441-011-1246-y (2012).","journal-title":"Cell and Tissue Research"},{"key":"28490_CR27","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/j.1582-4934.2008.00260.x","volume":"12","author":"OA Gressner","year":"2008","unstructured":"Gressner, O. A. et al. Activation of TGF-\u03b2 within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor. Journal of Cellular and Molecular Medicine 12, 2717\u20132730, https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00260.x (2008).","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"28490_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/gut.2005.088690","volume":"56","author":"Y Inagaki","year":"2007","unstructured":"Inagaki, Y. & Okazaki, I. Emerging insights into Transforming growth factor \u03b2 Smad signal in hepatic fibrogenesis. Gut 56, 284\u2013292, https:\/\/doi.org\/10.1136\/gut.2005.088690 (2007).","journal-title":"Gut"},{"key":"28490_CR29","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/17826","volume":"397","author":"L Ulloa","year":"1999","unstructured":"Ulloa, L., Doody, J. & Massagu\u00e9, J. Inhibition of transforming growth factor-\u03b2\/SMAD signalling by the interferon-\u03b3\/STAT pathway. Nature 397, 710\u2013713, https:\/\/doi.org\/10.1038\/17826 (1999).","journal-title":"Nature"},{"key":"28490_CR30","doi-asserted-by":"publisher","first-page":"167sr161","DOI":"10.1126\/scitranslmed.3004700","volume":"5","author":"SL Friedman","year":"2013","unstructured":"Friedman, S. L., Sheppard, D., Duffield, J. S. & Violette, S. Therapy for Fibrotic Diseases: Nearing the Starting Line. Science Translational Medicine 5, 167sr161\u2013167sr161, https:\/\/doi.org\/10.1126\/scitranslmed.3004700 (2013).","journal-title":"Science Translational Medicine"},{"key":"28490_CR31","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","volume":"43","author":"Y Popov","year":"2005","unstructured":"Popov, Y., Patsenker, E., Fickert, P., Trauner, M. & Schuppan, D. Mdr2 (Abcb4)\u2212\/\u2212 mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. Journal of Hepatology 43, 1045\u20131054, https:\/\/doi.org\/10.1016\/j.jhep.2005.06.025 (2005).","journal-title":"Journal of Hepatology"},{"key":"28490_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/jgh.12042","volume":"28","author":"M Goodwin","year":"2013","unstructured":"Goodwin, M. et al. Advanced glycation end products augment experimental hepatic fibrosis. Journal of Gastroenterology and Hepatology 28, 369\u2013376, https:\/\/doi.org\/10.1111\/jgh.12042 (2013).","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"28490_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.freeradbiomed.2012.05.007","volume":"53","author":"JX Jiang","year":"2012","unstructured":"Jiang, J. X. et al. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831 a novel NOX4\/NOX1 inhibitor in vivo. Free radical biology & medicine 53, 289\u2013296, https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.05.007 (2012).","journal-title":"Free radical biology & medicine"},{"key":"28490_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jhep.2009.03.024","volume":"51","author":"JX Jiang","year":"2009","unstructured":"Jiang, J. X., Mikami, K., Venugopal, S., Li, Y. & T\u00f6r\u00f6k, N. J. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK\/STAT and Akt\/NF-\u03baB-dependent pathways. Journal of Hepatology 51, 139\u2013148, https:\/\/doi.org\/10.1016\/j.jhep.2009.03.024 (2009).","journal-title":"Journal of Hepatology"},{"key":"28490_CR35","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1053\/j.gastro.2010.05.074","volume":"139","author":"JX Jiang","year":"2010","unstructured":"Jiang, J. X. et al. NOX2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. Gastroenterology 139, 1375\u20131384.e1374, https:\/\/doi.org\/10.1053\/j.gastro.2010.05.074 (2010).","journal-title":"Gastroenterology"},{"key":"28490_CR36","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1053\/jhep.2003.50472","volume":"38","author":"A Canbay","year":"2003","unstructured":"Canbay, A. et al. Kupffer Cell Engulfment of Apoptotic Bodies Stimulates Death Ligand and Cytokine Expression. Hepatology 38, 1188\u20131198, https:\/\/doi.org\/10.1053\/jhep.2003.50472 (2003).","journal-title":"Hepatology"},{"key":"28490_CR37","first-page":"1237","volume":"145","author":"TH Mauad","year":"1994","unstructured":"Mauad, T. H. et al. Mice with Homozygous Disruption of the mdr2 P-Glycoprotein Gene A Novel Animal Model for Studies of Nonsuppurative Inflammatory Cholangitis and Hepatocarcinogenesis. The American Journal of Pathology 145, 1237\u20131245 (1994).","journal-title":"The American Journal of Pathology"},{"key":"28490_CR38","doi-asserted-by":"publisher","first-page":"G98","DOI":"10.1152\/ajpgi.00045.2009","volume":"297","author":"CB Herath","year":"2009","unstructured":"Herath, C. B. et al. Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2. American Journal of Physiology - Gastrointestinal and Liver Physiology 297, G98\u2013G106, https:\/\/doi.org\/10.1152\/ajpgi.00045.2009 (2009).","journal-title":"American Journal of Physiology - Gastrointestinal and Liver Physiology"},{"key":"28490_CR39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jhep.2007.03.008","volume":"47","author":"CB Herath","year":"2007","unstructured":"Herath, C. B. et al. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis. J Hepatol 47, 387\u2013395, https:\/\/doi.org\/10.1016\/j.jhep.2007.03.008 (2007).","journal-title":"J Hepatol"},{"key":"28490_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.rinim.2014.08.001","volume":"4","author":"H Kitani","year":"2014","unstructured":"Kitani, H. et al. Establishment of c-myc-immortalized Kupffer cell line from a C57BL\/6 mouse strain. Results in Immunology 4, 68\u201374, https:\/\/doi.org\/10.1016\/j.rinim.2014.08.001 (2014).","journal-title":"Results in Immunology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28490-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28490-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28490-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:09:58Z","timestamp":1671606598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-28490-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["28490"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-28490-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,5]]},"assertion":[{"value":"29 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10175"}}